Price
No data yet.
Social Signal Score
Analyst Ratings
8 analystsRevenue
$994.15M+1521.25%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Virgilio Deloy Capobianco Gibbon
- Sector
- Consumer Defensive
- Industry
- Education & Training Services
- Employees
- 9,395
- Beta
- 0.38
- Country
- BR
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 2.23
Financials
Revenue
$994.15M+1521.3%Net Income
$201.59M+1051.2%EBITDA
$391.38M+1772.8%Free Cash Flow
$173.34M+1144.1%EPS (diluted)
$2.27+1035.0%Shares Outstanding (diluted)
89.30M+1.8%Operating Expenses
$313.54MCash & Debt
$1.00BReturn of Capital
$67.69MDividend per Share
$0.66Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.62B | $737.68M | $8.16 |
| 2024 | $3.30B | $631.51M | $7.01 |
| 2023 | $2.88B | $386.32M | $4.27 |
| 2022 | $2.33B | $373.57M | $4.15 |
| 2021 | $1.72B | $223.33M | $2.39 |
| 2020 | $1.20B | $292.07M | $3.15 |
| 2019 | $750.63M | $153.92M | $2.03 |
| 2018 | $333.94M | $86.35M | $0.98 |
| 2017 | $216.01M | $45.39M | $0.52 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from AFYA's reported EPS growth of 41.1% a year over 8 years. Historical EPS growth of 41% reflects a recovery from a low base and won't persist. Capped at 30% as a starting point.
- EPS in 5 years
- $30.27
- Implied price
- $302.73
- Return from $12.22
- 90.0% a year
To earn 15.0% a year on these assumptions you'd need to buy at $150.51 — today's price is already 91.9% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 6 | 8 | 10 | 12 | 14 |
|---|---|---|---|---|---|
| 20.0% | 58.4% | 67.7% | 75.4% | 81.9% | 87.6% |
| 25.0% | 65.0% | 74.7% | 82.7% | 89.5% | 95.4% |
| 30.0% | 71.6% | 81.7% | 90.0% | 97.1% | 103.2% |
| 35.0% | 78.2% | 88.7% | 97.3% | 104.7% | 111.1% |
| 40.0% | 84.8% | 95.7% | 104.6% | 112.2% | 118.9% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
103-31.11%Social Signal Score
Mentions (16)
- Newsbusinesswire.com·4d ago·Negative
Merger Agreement and Other Covenants Entered Into by and Between AFYA LIMITED and YDUQS PARTICIPAÇÕES S.A. BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34): Dated September 23, 2026 MERGER AGREEMENT AND OTHER COVENANTS This Merger Agreement and Other Covenants (“Agreement”), dated as of September 23, 2026, is entered into by and among: (1) AFYA LIMITED, an exempted company duly incorporated and existing under the laws of the Cayman Islands, with its registered off…
View source ↗ - Newsbusinesswire.com·4d ago·Negative
…a Limited and YDUQS Participações S.A. Controlling Shareholders Enter Into Voting Commitment Agreement BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34): VOTING COMMITMENT AGREEMENT entered into by and among As Parties ROSE FUNDO DE INVESTIMENTO EM PARTICIPAÇÕES MULTIESTRATÉGIA CHAIM ZAHER TCA 2 FUNDO DE INVESTIMENTO EM AÇÕES NTCA NOVOS NEGÓCIOS EDUCACIONAIS LTDA. ERSTE WV GÜTERSLOH GMBH NICOLAU CARVALHO ESTEVES NRE CAPITAL VENTURES LTD. As Intervening Consenting P…
View source ↗ - Newsbusinesswire.com·4d ago·Neutral
Afya Limited to Host Afya Day 2026 on October 20th in Rio de Janeiro BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that it will host its Afya Day on October 20th, 2026. At the event, Afya's executives will present the company's strategic evolution, business priorities and perspectives for sustainable value creation. The recording of …
View source ↗ - Newsseekingalpha.com·11d ago·Positive
Afya Limited (AFYA) M&A Call Transcript Afya Limited (AFYA) M&A Call Transcript
View source ↗ - Newszacks.com·12d ago·Neutral
New Strong Sell Stocks for September 24th AGCO, AGBK and AFYA have been added to the Zacks Rank #5 (Strong Sell) List on September 24th, 2026.
View source ↗ - Newsbusinesswire.com·12d ago·Negative
Afya Limited and Yduqs Participações S.A. Enter Into Merger Agreement BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), announced today that it has entered into a binding merger agreement with Yduqs Participações S.A. (B3: YDUQ3) (“Yduqs” and, together with Afya, the “Companies”) providing for a business combination of the two companies (the “Proposed Transaction”). The Proposed Transaction brings together two major Brazilian higher educa…
View source ↗ - Newsbusinesswire.com·18d ago·Neutral
Afya Limited Announces Medical Seats Increase in AFYA Cruzeiro do Sul BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) authorized the increase of 17 medical seats of ITPAC Cruzeiro do Sul – Instituto Tocantinense Presidente Antonio …
View source ↗ - Newszacks.com·18d ago·Neutral
New Strong Sell Stocks for September 18th AGBK, AFYA and APTV have been added to the Zacks Rank #5 (Strong Sell) List on September 18th, 2026.
View source ↗ - Newszacks.com·34d ago·Neutral
New Strong Sell Stocks for September 2nd AGCO, AFYA and ASEKY have been added to the Zacks Rank #5 (Strong Sell) List on September 2, 2026.
View source ↗ - Newsseekingalpha.com·38d ago·Negative
Afya Got Some Regulatory Respite But The Education Quality Risk Remains Afya Limited (AFYA) reported 2Q26 results showing revenue up 6% YoY, barely above inflation, with margin contraction and slowing student growth. Regulatory risks from ENAMED exam results persist, threatening both seat capacity and brand reputation, despite a temporary injunction lifting some restrictions. Pricing power has weakened, with tuition increases now only matching inflation, undermining the previous thesis of premiu…
View source ↗ - Newszacks.com·41d ago·Neutral
New Strong Sell Stocks for August 26th AFYA, APTV and CVCO have been added to the Zacks Rank #5 (Strong Sell) List on August 26th, 2026.
View source ↗ - Newsbusinesswire.com·43d ago·Neutral
…blic Disclosure Made by Yduqs Participações S.A. Regarding a Potential Business Combination BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that discussions with Yduqs Participações S.A. (B3: YDUQ3) ("Yduqs") regarding a potential business combination involving the two companies are at an early stage, following the material fact disclosed by Yduqs on this date, pursuant to Article 157, Paragraph 4 of Brazilian Law No. 6,404/1976 and CVM Resolution …
View source ↗ - Newszacks.com·53d ago·Negative
Afya (AFYA) Q2 Earnings and Revenues Lag Estimates Afya (AFYA) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.4 per share a year ago.
View source ↗ - Newsmarketbeat.com·53d ago·Neutral
Afya Q2 Earnings Call Highlights Afya NASDAQ: AFYA reported first-half 2026 revenue of BRL 1.985 billion, up 7% from a year earlier, while adjusted EBITDA rose 3% to BRL 918 million. Net income increased 7% to BRL 463 million, and basic earnings per share rose 9% to BRL 5.10.
View source ↗ - Newsseekingalpha.com·53d ago·Positive
Afya Limited (AFYA) Q2 2026 Earnings Call Transcript Afya Limited (AFYA) Q2 2026 Earnings Call Transcript
View source ↗ - Newsbusinesswire.com·53d ago·Neutral
Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2026 (second quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with Inter…
View source ↗
Earnings
Thu, Nov 12(in 5 weeks)
Consensus estimate $0.38 per share
Typical surprise +7.9% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 13$0.45 vs $0.39beat
- Thu, May 7$0.56 vs $0.53beat
- Thu, Mar 12$0.41 vs $0.38beat
- Wed, Nov 12$0.38 vs $0.32beat
- Wed, Aug 13$0.40 vs $0.40beat
- Thu, May 8$0.55 vs $0.46beat
Estimates and results for AFYA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by AFYA officers and directors.
- Bought
- —
- Sold
- $3.2m
0 trades
19 trades
- Junior Lelio De Souzasold
- Basolli Gomiero Mirellasold
- Junior Lelio De Souzasold
- Ferreira Santos Weldersold
- Grifo De Sousa Anibal Josesold
- Grifo De Sousa Anibal Josesold
- Grifo De Sousa Anibal Josesold
- Junior Lelio De Souzasold
77 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in AFYA.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.